Does a lifesaving HIV drug cause weight problems for moms and babies?

This study aims to understand if a common HIV medication called dolutegravir causes excess weight gain during pregnancy and affects the long-term metabolic health of both mothers and their children. Researchers will follow about 1,900 pregnant women, some with HIV and some without, for up to five years after birth, tracking weight, body fat, and other health markers. The goal is to gather information to help guide safer treatment choices for pregnant women living with HIV.